6 withdrawn, 1 completed, 1 terminated. 7 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Withdrawn 5, Completed 1, Terminated 1 |
| Phase 1 | 3 | Withdrawn 3 |
Follow STI-2020: new trials by email Literature Review of STI-2020 trials Research Report on STI-2020
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (US) COVI-DROPS, Placebo - Covid19 | Phase 2 | Completed | Sorrento Therapeutics, Inc. | 97 | 2021-11-16 | 2022-02-03 |
| Randomized Study to Evaluate Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With Mild COVID-19 Infection COVI-DROPS, Placebo - COVID-19 | Phase 2 | Withdrawn | Sorrento Therapeutics, Inc. | 2021-11-01 | 2022-02-03 | |
| Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (UK) COVI-DROPS, Placebo - Covid19 | Phase 2 | Terminated | Sorrento Therapeutics, Inc. | 179 | 2021-07-16 | 2023-01-30 |
| Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Hospitalized Adults With COVID-19 COVI-AMG, Placebo - Covid19 | Phase 2 | Withdrawn | Sorrento Therapeutics, Inc. | 2021-04-01 | 2022-08-16 | |
| Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) to Treat COVID-19 COVI-AMG, Placebo - Covid19 | Phase 1 / Phase 2 | Withdrawn | Sorrento Therapeutics, Inc. | 2021-04-01 | 2022-02-25 | |
| Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms COVI-AMG, Placebo - Covid19 | Phase 2 | Withdrawn | Sorrento Therapeutics, Inc. | 2021-04-01 | 2022-02-25 | |
| Study to Evaluate the Safety, Pharmacokinetics and Efficacy of STI-2020 (COVI-AMG™) in Outpatients With COVID-19 COVI-AMG, Placebo - Covid19 | Phase 1 / Phase 2 | Withdrawn | Sorrento Therapeutics, Inc. | 2020-12-01 | 2021-02-12 | |
| Study to Evaluate STI-1499 (COVI-GUARD) in Patients With Moderate COVID-19 COVI-GUARD, Standard of Care, Placebo - Covid-19 | Phase 1 | Withdrawn | Sorrento Therapeutics, Inc. | 2020-09-01 | 2021-01-08 |
COVID-19 (8)
Sorrento Therapeutics, Inc. (8)
United States (3) · United Kingdom (1)
Mike Royal, MD (8)